Abstract
Background
In recent years, an increasing incidence of inflammatory bowel disease (IBD) has been reported, mainly as Crohn’s disease (CD) and ulcerative colitis (UC). The individual susceptibility, the disease’s course and response to the applied therapy is likely due to genetic factors such as ABCB1 gene mutations, exemplified by C3435T polymorphism.
The aim of the study was to evaluate the distribution of C3435T polymorphism regarding the gender in IBD patients and control subjects from Lower Silesia region and its possible association with IBD susceptibility.
Methods
The research was conducted in groups of 61 IBD patients and 101 healthy subjects from the Lower Silesia region. Polymorphism of C3435T was determined using PCR-RFLP method.
Results
Frequency distributions of C3435T genotype and of 3435T or 3435C gene alleles of IBD, CD or UC patients were compared to control group; each treated as a whole or split further by gender. The statistically significant correlation was discovered between gender and C3435T genotype both for IBD and CD patients, with 3435CT heterozygote prevailing in IBD and CD males.
Odds ratio calculations revealed statistically significant difference for the 3435CT genotype between control and: IBD group considered as a whole; IBD males; CD males; and for 3435TT variant between control and IBD males. Conclusions. The 3435CT genotype could be a risk factor for IBD and CD in men. The 3435TT genotype in males seems to be associated with the lower chance of IBD presence.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barańska M, Skrętkowicz J. Perspective of gene therapy (Polish). Wiad Lek 2007;60(7–8):305–11.
Wojtczak A, Skrętkowicz J. Clinical significance of some genetic polymorphisms of cytochrome P-450: family CYP1 and subfamilies CYP2A, CYP2B and CYP2C (Polish). Pol Merkuriusz Lek 2009;26:248–52.
Kim RB, Leake BF, Dresser GK, Kubba SV, Schwarz UJ, Taylor A, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001;70(20):189–99.
Navratil V, Penel S, Delmotte S, Mouchiroud D, Gautier C, Aouacheria A. DigiPINS: A database for vertebrate exonic single nucleotide polymorphisms and its application to cancer association studies. Biochemie 2008;90(4):563–9.
Neuhausen SL, Steele L, Ryan S. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun 2008;31(2):160–5.
Shepshelovich D, Shoenfeld Y. Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 2006; 15(3):183–90.
Urcelay E, Mendoza JL, Martin MC, Mas A, Martinez A, Taxonera C, et al. MDR1 gene: susceptibility in Spanish Crohn’s disease and ulcerative colitis patients. Inflamm Bowel Dis 2006;12:33–7.
van Oene M, Wintle RF, Lue X. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn’s disease, in Canadian populations. Arthritis Rheum 2005;52:1993–8.
Ho GT, Soranzo N, Nimmo ER, Tenesa A, Goldstein DB, Satsangi J. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet 2006;15(5):787–805.
Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriolli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol 2006;12(23):3636–44.
Potočnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 2004;5(7):530–9.
van Heel DA, Fischer SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Genome Scan Meta-Analysis Group of the IBD International Genetics Consortium: Inflammatory Bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004;13(7):763–70.
Brant SR, Panhuysen CIM, Nicolae D, Reddy DM, Bonen DK, Karahukas R, et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 2003;73(6):1282–92.
Hołysz H, Rubiś B. Contribution of ABCB1 gene polymorphisms to breast cancer cells response to chemotherapy (Polish). Przegl Menopauz 2013;4: 321–7.
Hitzl M, Drescher S, van der Kuip H, Schäffeler E, Fischer J, Schwab M, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001;11(4):293–8.
Dudarewicz M, Barańska M, Skrętkowicz J. Importance of selected polymorphisms of ABCB1 (MDR1) gene in inflammatory bowel diseases (Polish). Przegl Gastroenterol 2010;5(6):310–4.
Ho RH, Kim RB. Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 2005;78:260–77.
Hoffmeyer S, Burk O, von Richter O, Arhold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97(7):3473–8.
Liao B, Li X, Zhu W, Li R, Wang S. Multiple ant colony algorithm method for selecting tag SNPs. J Biomed Inform 2012;45(5):931–7.
Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, et al. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol. Clin Pharmacol Ther 2002;72(5):572–83.
Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM, et al. Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 2001;358(9279):383–4.
Ardizzone S, Maconi G, Bianchi V, Russo A, Colombo E, Cassinotti A, et al. Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm Bowel Dis 2007;13(5):516–23.
Onnie MC, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, et al. Association of allelic variants of the Multidrug Resistance Gene (ABCB1, MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis 2006;12(4):263–71.
Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, et al. Associations between the C3435T MDR1 gene polymorphism and susceptibility for ulceratice colitis. Gastroenterology 2003;124(1):26–33.
Gazouli M, Zacharatos P, Gorgoulis V, Mantzaris G, Papalarubros E, Ikonomo-poulos I. The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population. Gastroenterology 2004;126(1):367–9.
Osuga T, Sakaeda T, Nakamura T, Hamada T, Koyama T, Tamura T, et al. MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese. Biol Pharm Bull 2006;29(2):324–9.
Farnood A, Naderi N, Moghaddam SJM, Noorinayer B, Firouzi F, Aghazadeh R, et al. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis 2007;22(9):999–1003.
Palmieri O, Latiano A, Valvano R, D’Inca R, Vecchi M, Sturniolo GC, et al. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients. Aliment Pharmacol Ther 2005;22(11–12):1129–38.
Jamroziak K, Balcerczak E, Młynarski W, Mirowski M, Robak T. Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population. Pol J Pharmacol 2002;54(5):495–500.
Kurzawski M, Pawlik A, Górnik W, Droździk M. Frequency of common MDR1 gene variants in Polish population. Pharmacol Rep 2006;58(1):35–40.
Dudarewicz M, Barańska M, Rychlik-Sych M, Trzciński R, Dziki A, Skrętkowicz J. C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in Polish population. Pharmacol Rep 2012;64(2):343–50.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jaźwińska-Tarnawska, E., Jęśkowiak, I., Waszczuk, E. et al. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?. Pharmacol. Rep 67, 294–298 (2015). https://doi.org/10.1016/j.pharep.2014.09.014
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2014.09.014